Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Ana Gleisner

Concepts (278)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreatic Neoplasms
16
2022
704
3.550
Why?
Laparoscopy
8
2021
395
2.960
Why?
Pancreaticoduodenectomy
10
2021
134
2.670
Why?
Adenocarcinoma
17
2022
808
2.600
Why?
Sentinel Lymph Node
7
2021
38
2.490
Why?
Skin Neoplasms
11
2021
755
2.440
Why?
Melanoma
11
2021
718
2.440
Why?
Pancreatectomy
4
2021
152
2.030
Why?
Lymph Node Excision
8
2021
143
1.820
Why?
Minimally Invasive Surgical Procedures
5
2020
141
1.560
Why?
Liver Neoplasms
15
2016
457
1.410
Why?
Sentinel Lymph Node Biopsy
9
2021
126
1.370
Why?
Postoperative Complications
10
2021
2181
1.330
Why?
Hepatectomy
11
2021
127
1.230
Why?
Esophagectomy
4
2021
73
1.170
Why?
Robotic Surgical Procedures
3
2019
65
1.100
Why?
Conversion to Open Surgery
2
2020
14
1.010
Why?
Nomograms
2
2022
52
0.980
Why?
Esophageal Neoplasms
6
2021
239
0.880
Why?
Lymph Nodes
6
2020
476
0.880
Why?
Retrospective Studies
39
2022
11642
0.840
Why?
Survival Rate
21
2021
1859
0.820
Why?
Aged
44
2022
20218
0.720
Why?
Quality of Life
2
2019
2230
0.720
Why?
Head and Neck Neoplasms
6
2019
420
0.670
Why?
Rectal Neoplasms
4
2022
107
0.670
Why?
Lymphatic Metastasis
9
2020
313
0.650
Why?
Colorectal Neoplasms
7
2017
589
0.650
Why?
Middle Aged
51
2022
28854
0.640
Why?
Colectomy
3
2013
81
0.590
Why?
Prognosis
18
2020
3546
0.590
Why?
Carcinoma, Pancreatic Ductal
3
2022
180
0.570
Why?
Neoplasm Recurrence, Local
7
2019
805
0.560
Why?
Liver Transplantation
9
2009
751
0.560
Why?
Liver Failure
3
2009
86
0.560
Why?
Colonic Neoplasms
2
2013
216
0.510
Why?
Neoplasm Staging
8
2022
1215
0.510
Why?
Humans
75
2022
114571
0.500
Why?
Female
60
2022
63070
0.500
Why?
Risk Assessment
5
2019
3208
0.480
Why?
Neoadjuvant Therapy
8
2022
283
0.470
Why?
Decision Making
1
2019
799
0.470
Why?
Male
56
2022
60817
0.470
Why?
Breast Neoplasms
3
2020
1925
0.470
Why?
Follow-Up Studies
13
2021
4950
0.450
Why?
Treatment Outcome
18
2021
9190
0.430
Why?
Databases, Factual
6
2019
1161
0.390
Why?
Benchmarking
2
2021
156
0.380
Why?
Aged, 80 and over
16
2021
6818
0.380
Why?
Single Photon Emission Computed Tomography Computed Tomography
2
2019
16
0.370
Why?
Peritoneal Neoplasms
2
2020
53
0.370
Why?
Propensity Score
2
2019
252
0.350
Why?
Mastectomy, Segmental
2
2017
89
0.330
Why?
Length of Stay
4
2019
1071
0.330
Why?
Catheter Ablation
2
2008
325
0.300
Why?
Carcinoma, Hepatocellular
3
2016
193
0.290
Why?
Margins of Excision
3
2019
31
0.290
Why?
Hyperglycemia
2
2020
336
0.290
Why?
Adult
28
2022
32077
0.280
Why?
Abdomen, Acute
1
2004
19
0.270
Why?
Bacterial Infections
3
2006
214
0.270
Why?
Axilla
2
2020
61
0.250
Why?
SEER Program
2
2014
206
0.250
Why?
Odds Ratio
4
2019
1059
0.250
Why?
Lymphoscintigraphy
2
2019
13
0.250
Why?
Sunburn
1
2002
35
0.240
Why?
Sunscreening Agents
1
2002
24
0.240
Why?
Nevus, Pigmented
1
2002
39
0.240
Why?
Pelvic Exenteration
2
2019
11
0.230
Why?
Survival Analysis
6
2017
1410
0.230
Why?
Klatskin Tumor
1
2021
4
0.230
Why?
Anesthetics, Inhalation
1
2021
19
0.220
Why?
Cytoreduction Surgical Procedures
2
2020
43
0.220
Why?
Bile Duct Neoplasms
1
2021
54
0.220
Why?
Propofol
1
2021
46
0.210
Why?
Prospective Studies
8
2022
6288
0.210
Why?
Hyperthermia, Induced
2
2020
72
0.210
Why?
Cohort Studies
8
2019
5000
0.210
Why?
United States
12
2021
12551
0.210
Why?
Disease-Free Survival
6
2022
685
0.200
Why?
Anesthesia
1
2021
86
0.200
Why?
Scalp
1
2019
25
0.200
Why?
Reoperation
3
2017
546
0.200
Why?
Combined Modality Therapy
5
2019
1217
0.190
Why?
Registries
2
2021
1915
0.190
Why?
Pancreatic Diseases
1
2019
64
0.190
Why?
Regression Analysis
2
2019
1109
0.180
Why?
Skin Pigmentation
1
2019
51
0.180
Why?
Appendiceal Neoplasms
1
2017
10
0.170
Why?
Patient Reported Outcome Measures
1
2019
216
0.170
Why?
Common Bile Duct Neoplasms
1
2017
15
0.170
Why?
Ampulla of Vater
1
2017
22
0.170
Why?
Population Surveillance
1
2021
440
0.170
Why?
Waiting Lists
2
2009
195
0.170
Why?
Gastric Outlet Obstruction
1
2017
7
0.160
Why?
Pylorus
1
2017
11
0.160
Why?
Patient Compliance
1
2021
609
0.160
Why?
Carcinoma, Ductal, Breast
1
2017
92
0.160
Why?
Genital Neoplasms, Female
1
2017
58
0.160
Why?
Nutritional Status
1
2019
282
0.160
Why?
Neuroendocrine Tumors
1
2017
69
0.160
Why?
Radiotherapy, Intensity-Modulated
1
2018
135
0.160
Why?
Cancer Care Facilities
1
2016
32
0.160
Why?
Hospitals, High-Volume
1
2016
51
0.160
Why?
Hospitals
1
2021
502
0.160
Why?
Neuromuscular Agents
1
2017
31
0.160
Why?
Disease Management
1
2021
605
0.160
Why?
Botulinum Toxins, Type A
1
2017
44
0.150
Why?
Chemoradiotherapy
3
2022
205
0.150
Why?
Organ Preservation
3
2022
87
0.150
Why?
Tomography, Emission-Computed, Single-Photon
1
2016
96
0.150
Why?
Adenoma
1
2017
185
0.150
Why?
Proportional Hazards Models
2
2022
1188
0.140
Why?
Tomography, X-Ray Computed
2
2016
2379
0.140
Why?
Time Factors
4
2021
7029
0.140
Why?
Anti-Bacterial Agents
1
2004
1366
0.140
Why?
Radiosurgery
1
2018
299
0.140
Why?
Phenotype
1
2002
2842
0.130
Why?
Delivery of Health Care
1
2021
734
0.130
Why?
Morbidity
4
2021
268
0.130
Why?
Kaplan-Meier Estimate
2
2013
899
0.130
Why?
Unnecessary Procedures
1
2014
47
0.130
Why?
Antineoplastic Agents
3
2021
2035
0.130
Why?
Patient Readmission
1
2019
664
0.130
Why?
Trauma Centers
2
2014
412
0.130
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2022
1390
0.130
Why?
Risk Factors
5
2019
9078
0.120
Why?
Abdomen
1
2013
124
0.120
Why?
Metastasectomy
1
2012
2
0.120
Why?
Radiation Dosage
1
2014
149
0.120
Why?
Clinical Competence
1
2019
935
0.120
Why?
Renal Insufficiency
1
2013
130
0.120
Why?
Asia
2
2021
60
0.110
Why?
Triage
1
2012
210
0.100
Why?
Carcinoma, Renal Cell
1
2012
175
0.100
Why?
Europe
2
2021
332
0.100
Why?
Kidney Transplantation
2
2013
520
0.100
Why?
Age Factors
4
2022
3280
0.100
Why?
Organ Preservation Solutions
2
2006
39
0.090
Why?
Graft Survival
2
2009
454
0.090
Why?
Practice Guidelines as Topic
1
2017
1541
0.090
Why?
Brain Injuries
1
2014
479
0.090
Why?
Practice Patterns, Physicians'
1
2017
1241
0.090
Why?
Laparotomy
1
2008
113
0.090
Why?
Bile Ducts, Extrahepatic
1
2008
25
0.090
Why?
Kidney Neoplasms
1
2012
330
0.090
Why?
Biliary Tract Surgical Procedures
1
2008
27
0.090
Why?
Gallbladder Neoplasms
1
2007
11
0.090
Why?
Neoplasm Invasiveness
3
2020
450
0.090
Why?
Neoplasms
1
2021
2065
0.080
Why?
Intraoperative Care
1
2007
48
0.080
Why?
Cholangitis, Sclerosing
1
2008
63
0.080
Why?
Young Adult
7
2022
10987
0.080
Why?
Case-Control Studies
2
2007
3249
0.080
Why?
Anus Neoplasms
1
2007
22
0.080
Why?
Electrocoagulation
1
2007
33
0.080
Why?
Chemotherapy, Adjuvant
3
2015
327
0.080
Why?
Brazil
2
2008
117
0.080
Why?
Congenital Hypothyroidism
1
1986
12
0.080
Why?
Fluorouracil
2
2022
141
0.080
Why?
Hospital Mortality
3
2019
871
0.080
Why?
Ultrasonography, Interventional
1
2007
148
0.080
Why?
Mycophenolic Acid
1
2006
81
0.070
Why?
Adolescent
8
2022
18658
0.070
Why?
Wounds and Injuries
1
2012
892
0.070
Why?
Zygomycosis
1
2003
6
0.070
Why?
Severity of Illness Index
2
2009
2847
0.070
Why?
Radiotherapy, Adjuvant
2
2019
194
0.070
Why?
Developmental Disabilities
1
1986
250
0.060
Why?
Antibiotic Prophylaxis
1
2004
91
0.060
Why?
Hepatocytes
1
2004
205
0.060
Why?
Comorbidity
2
2022
1645
0.060
Why?
Appendicitis
1
2004
116
0.060
Why?
Capecitabine
1
2022
45
0.060
Why?
Carcinoma, Squamous Cell
1
2007
555
0.060
Why?
CA-19-9 Antigen
1
2022
14
0.060
Why?
Anesthesia, Intravenous
1
2021
14
0.060
Why?
Surgical Wound Infection
1
2004
225
0.060
Why?
Anesthetics, Intravenous
1
2021
39
0.050
Why?
Esophagogastric Junction
1
2021
42
0.050
Why?
Induction Chemotherapy
1
2021
53
0.050
Why?
Tumor Burden
1
2022
288
0.050
Why?
Thoracoscopy
1
2020
55
0.050
Why?
Liver
2
2006
1832
0.050
Why?
Models, Biological
1
2008
1807
0.050
Why?
Adenocarcinoma, Mucinous
1
2020
51
0.050
Why?
Image-Guided Biopsy
1
2019
35
0.050
Why?
Preoperative Period
1
2019
109
0.050
Why?
Perioperative Period
1
2017
45
0.040
Why?
Parotid Gland
1
2017
23
0.040
Why?
Operative Time
1
2017
112
0.040
Why?
Occipital Bone
1
2017
20
0.040
Why?
Gastric Emptying
1
2017
37
0.040
Why?
Carcinoma, Lobular
1
2017
59
0.040
Why?
Oxidative Stress
1
2004
1231
0.040
Why?
ROC Curve
2
2009
489
0.040
Why?
Perioperative Care
1
2018
128
0.040
Why?
Health Behavior
1
2002
713
0.040
Why?
Obesity
1
2010
2643
0.040
Why?
Neck
1
2017
87
0.040
Why?
Liver Cirrhosis
2
2008
204
0.040
Why?
Raffinose
2
2006
20
0.040
Why?
Sex Factors
1
2022
1971
0.040
Why?
Preoperative Care
2
2008
339
0.040
Why?
Consensus
1
2017
458
0.040
Why?
Allopurinol
2
2006
86
0.040
Why?
Glucose
1
2020
905
0.030
Why?
Quality Indicators, Health Care
1
2017
315
0.030
Why?
Lung Neoplasms
1
2007
2191
0.030
Why?
Glutathione
2
2006
335
0.030
Why?
Adenosine
2
2006
217
0.030
Why?
Glasgow Coma Scale
1
2014
154
0.030
Why?
Drug Administration Schedule
1
2015
808
0.030
Why?
Diagnostic Tests, Routine
1
2014
91
0.030
Why?
Vital Signs
1
2012
31
0.030
Why?
Guideline Adherence
1
2017
541
0.030
Why?
New South Wales
1
2012
10
0.030
Why?
Radiation Injuries
1
2014
136
0.030
Why?
Incidence
1
2019
2454
0.030
Why?
Baltimore
1
2012
50
0.030
Why?
Disease Progression
1
2020
2486
0.030
Why?
Italy
1
2012
94
0.030
Why?
Child
5
2014
17859
0.030
Why?
Child, Preschool
4
2014
9651
0.030
Why?
Hospital Costs
1
2012
126
0.030
Why?
Biological Therapy
1
2011
28
0.030
Why?
Pharmaceutical Preparations
1
2013
172
0.030
Why?
Chi-Square Distribution
1
2012
577
0.030
Why?
Injury Severity Score
1
2012
543
0.030
Why?
Glomerular Filtration Rate
1
2013
588
0.030
Why?
Infant, Newborn
2
2014
5045
0.020
Why?
Multivariate Analysis
1
2013
1600
0.020
Why?
Immunosuppressive Agents
1
2013
679
0.020
Why?
Carcinoembryonic Antigen
1
2008
36
0.020
Why?
Antimetabolites, Antineoplastic
1
2008
86
0.020
Why?
Infant
3
2014
8096
0.020
Why?
Fluorodeoxyglucose F18
1
2008
129
0.020
Why?
Cholecystectomy
1
2007
42
0.020
Why?
Retreatment
1
2007
70
0.020
Why?
Sensitivity and Specificity
1
2012
1920
0.020
Why?
Neoplasm, Residual
1
2007
91
0.020
Why?
Radiopharmaceuticals
1
2008
197
0.020
Why?
Incidental Findings
1
2007
82
0.020
Why?
Colorado
1
2017
4488
0.020
Why?
Hepatitis B
1
2007
44
0.020
Why?
Tablets, Enteric-Coated
1
2006
4
0.020
Why?
Positron-Emission Tomography
1
2008
303
0.020
Why?
Histidine
1
2006
64
0.020
Why?
Biopsy, Needle
1
2007
194
0.020
Why?
Psychological Tests
1
1986
147
0.020
Why?
Radiography
1
2008
850
0.020
Why?
Overweight
1
2010
481
0.020
Why?
Tryptophan
1
2006
135
0.020
Why?
Graft Rejection
1
2009
591
0.020
Why?
Insulin
2
2006
2151
0.020
Why?
Glutathione Disulfide
1
2004
37
0.020
Why?
Hepatitis C
1
2007
218
0.020
Why?
Sulfamethoxypyridazine
1
1983
1
0.020
Why?
Trimethoprim
1
1983
9
0.020
Why?
Liver Function Tests
1
2004
116
0.020
Why?
Anti-Infective Agents, Urinary
1
1983
15
0.020
Why?
Gastrointestinal Diseases
1
2006
200
0.020
Why?
Amphotericin B
1
2003
37
0.020
Why?
Liver Diseases
1
2006
274
0.020
Why?
Antifungal Agents
1
2003
129
0.020
Why?
Patient Selection
1
2007
707
0.020
Why?
Urinary Tract Infections
1
1983
126
0.010
Why?
Cause of Death
1
2004
390
0.010
Why?
Body Mass Index
1
2010
2052
0.010
Why?
Immunocompromised Host
1
2003
213
0.010
Why?
Reperfusion Injury
1
2004
291
0.010
Why?
Sulfamethoxazole
1
1983
6
0.000
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
1983
39
0.000
Why?
Escherichia coli Infections
1
1983
124
0.000
Why?
Drug Combinations
1
1983
303
0.000
Why?
Microbial Sensitivity Tests
1
1983
296
0.000
Why?
Escherichia coli
1
1983
795
0.000
Why?
Clinical Trials as Topic
1
1983
1004
0.000
Why?
Gleisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)